Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A Lot is Happening in Migraine and Headache Therapy!].
Holle-Lee D, Sommer C. Holle-Lee D, et al. Fortschr Neurol Psychiatr. 2024 Jul;92(7-08):266. doi: 10.1055/a-2315-2100. Epub 2024 Jul 18. Fortschr Neurol Psychiatr. 2024. PMID: 39025055 German. No abstract available.
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
Goadsby PJ, Friedman DI, Holle-Lee D, Demarquay G, Ashina S, Sakai F, Neel B, Gandhi P, Dabruzzo B, Smith JH, Liu Y, Trugman JM. Goadsby PJ, et al. Among authors: holle lee d. Neurology. 2024 Jul 23;103(2):e209584. doi: 10.1212/WNL.0000000000209584. Epub 2024 Jun 26. Neurology. 2024. PMID: 38924724 Free PMC article. Clinical Trial.
[Digitalization in Migraine Therapy].
Lindner D, Holle-Lee D, Scheffler A. Lindner D, et al. Among authors: holle lee d. Fortschr Neurol Psychiatr. 2024 Jul;92(7-08):289-293. doi: 10.1055/a-2314-2960. Epub 2024 May 23. Fortschr Neurol Psychiatr. 2024. PMID: 38781988 Review. German.
Hypnic Headache - What do we know in 2022?
Lindner D, Scheffler A, Nsaka M, Holle-Lee D. Lindner D, et al. Among authors: holle lee d. Cephalalgia. 2023 Mar;43(3):3331024221148659. doi: 10.1177/03331024221148659. Cephalalgia. 2023. PMID: 36786376 Free article. Review.
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients.
Fleischer M, Szepanowski F, Tovar M, Herchert K, Dinse H, Schweda A, Mausberg AK, Holle-Lee D, Köhrmann M, Stögbauer J, Jokisch D, Jokisch M, Deuschl C, Skoda EM, Teufel M, Stettner M, Kleinschnitz C. Fleischer M, et al. Among authors: holle lee d. Neurol Ther. 2022 Dec;11(4):1637-1657. doi: 10.1007/s40120-022-00395-z. Epub 2022 Aug 26. Neurol Ther. 2022. PMID: 36028604 Free PMC article.
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Nahas SJ, et al. Among authors: holle lee d. J Headache Pain. 2022 May 17;23(1):57. doi: 10.1186/s10194-022-01423-x. J Headache Pain. 2022. PMID: 35581545 Free PMC article. No abstract available.
31 results